CURLF CURALEAF HOLDINGS INC
- 5.600
- +0.100+1.82%
CURALEAF HOLDINGS INC News
Cannabis Shops Could Launch This Year In Germany For 'Scientific Purposes,' Here's Why UK's Medical Marijuana Sales Are Soaring
Over the last several years, Europe has become more open-minded about medical and recreational marijuana. Here are some of the latest cannabis developments from the United Kingdom and Germany. Germany
Cannabis Reports Highlight $339M And $297.6M Revenue Insights In Curaleaf And Trulieve's Q1 2024 Financials
A recent Beacon Securities report focuses on Curaleaf's strategic financial management and the potential impacts of legislative changes on its operations. Concurrently, Needham's report highlights Tru
CURALEAF HOLDINGS INC | 6-K: Report of foreign private issuer (related to financial reporting)
Curaleaf Looks to Follow Trulieve's Tax-Slashing Strategy
By Dean Seal Curaleaf Holdings tentatively plans to claim it isn't subject to a burdensome tax code that has sapped the cannabis industry's profits for years, following in the footsteps of a rival th
Needham: Maintaining the Curaleaf Holdings (CURLF.US) rating, adjusted from buy to buy rating, and adjusted the target price from $5.25 to $6.25.
Needham: Maintaining the Curaleaf Holdings (CURLF.US) rating, adjusted from buy to buy rating, and adjusted the target price from $5.25 to $6.25.
Needham Maintains Buy on Curaleaf Holdings, Raises Price Target to $6.25
Needham analyst Matt McGinley maintains Curaleaf Holdings (OTC:CURLF) with a Buy and raises the price target from $5.25 to $6.25.
Curaleaf Holdings Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 13.64% Needham $5.25 → $6.25 Maintains Buy 03/08/2024 9.09% Wedbush $4.5 → $6 Maintains Outperf
Curaleaf Reports Q1 2024 Revenue Of $339M, 48% Gross Margin Amid Strategic Global Expansion
Curaleaf Holdings, Inc. (OTC:CURLF), a leading international cannabis company, reported its financial results for the first quarter of 2024. Curaleaf's CEO, Matt Darin, highlighted the company's focus
Curaleaf Narrows 2Q Loss as Sales Edge Higher
By Dean Seal Curaleaf Holdings narrowed its loss in the first quarter as sales in its retail and wholesale channels ticked higher. The largest U.S. cannabis company by revenue posted a loss of $48.3
Press Release: Curaleaf Reports First Quarter 2024 Results
Curaleaf Reports First Quarter 2024 Results Canada NewsWire NEW YORK, May 9, 2024 First quarter 2024 revenue of $339 million, representing an increase of 2% year-over-year and adjusted gross margin
Medical Marijuana Giant Trulieve, Backer Of Florida's Recreational Cannabis Ballot, Narrows Loss, Reports Uptick In Q1 Revenue, Gross Profit
Trulieve Cannabis Corp. (CSE:TRUL) (OTCQX:TCNNF) announced its first quarter results for the three months ended March 31, 2024.The Tallahassee-based medical cannabis giant reported revenue of $298 mil
What Marijuana Reclassification Means for the US Cannabis Industry
Marijuana Stock Movers For May 7, 2024
GAINERS:Kaya Holdings (OTC:KAYS) shares closed up 51.29% at $0.05Elixinol Wellness (OTC:ELLXF) shares closed up 23.60% at $0.00Heritage Cannabis Holding (OTC:HERTF) shares closed up 15.00% at $0.00CV
Big Players In U.S. Cannabis Could Play The Stock-Value Card In M&A, New Report Shows
As the cannabis industry adapts to its new regulatory environment following the DEA's announcement it would move to
Cannabis Businesses Subject to Federal Marijuana Laws Under Rescheduling - CRS
EXCLUSIVE: 'Cannabis Is Just Getting Started,' Says This Top Stock Expert Who Knows How To Capitalize On Swing Trades
"Cannabis is just getting started and there's going to be a lot of companies getting ready to take advantage of this massive growth cycle, government reform, news states, opening new opportunities and
New Tax Rules In Cannabis: What Are The Consequences DEA Rescheduling?
In a significant shift for the cannabis industry, marijuana is set to be reclassified as a Schedule 3 controlled substance. While this change does not address the ongoing federal prohibition, removal
Marijuana Opposition Group Raising Money to Fight Cannabis Rescheduling
Billions On The Move: Tracking Market Cap Changes In Top Cannabis Firms After DEA Rescheduling Announcement
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injected billions into the publicly traded market for cannabis companies. But w
Pot Stocks Rally Snuffed Day After DEA Marijuana Rescheduling Development
Analysis
Price Target
No Data
